ITREND_MEDICAL_RESEARCH_L - Accounts


Company Registration No. 10520699 (England and Wales)
ITREND MEDICAL RESEARCH LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021
PAGES FOR FILING WITH REGISTRAR
ITREND MEDICAL RESEARCH LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
ITREND MEDICAL RESEARCH LIMITED
BALANCE SHEET
AS AT
31 MARCH 2021
31 March 2021
- 1 -
2021
2020
Notes
£
£
£
£
Current assets
Debtors
4
10,990
48,343
Cash at bank and in hand
4,941
36,875
15,931
85,218
Creditors: amounts falling due within one year
5
(190,493)
(59,335)
Net current (liabilities)/assets
(174,562)
25,883
Capital and reserves
Called up share capital
1,000
1,000
Share premium account
599,000
599,000
Profit and loss reserves
(774,562)
(574,117)
Total equity
(174,562)
25,883

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 13 December 2021
Mr M Morris
Director
Company Registration No. 10520699
ITREND MEDICAL RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021
- 2 -
1
Accounting policies
Company information

Itrend Medical Research Limited is a private company limited by shares incorporated in England and Wales. The registered office is 3 New Park Place, Pride Park, Derby, DE24 8DZ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

ITREND MEDICAL RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
- 3 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2021
2020
Number
Number
Total
1
1
4
Debtors
2021
2020
Amounts falling due within one year:
£
£
Other debtors
10,990
48,343
5
Creditors: amounts falling due within one year
2021
2020
£
£
Trade creditors
67,983
56,397
Taxation and social security
-
0
1,578
Other creditors
122,510
1,360
190,493
59,335
6
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

The following amounts were outstanding at the reporting end date:

2021
2020
Amounts due to related parties
£
£
Mstart
121,260
110
2021-03-312020-04-01false13 December 2021CCH SoftwareCCH Accounts Production 2021.200No description of principal activityMr M Morris105206992020-04-012021-03-31105206992021-03-31105206992020-03-3110520699core:CurrentFinancialInstrumentscore:WithinOneYear2021-03-3110520699core:CurrentFinancialInstrumentscore:WithinOneYear2020-03-3110520699core:CurrentFinancialInstruments2021-03-3110520699core:CurrentFinancialInstruments2020-03-3110520699core:ShareCapital2021-03-3110520699core:ShareCapital2020-03-3110520699core:SharePremium2021-03-3110520699core:SharePremium2020-03-3110520699core:RetainedEarningsAccumulatedLosses2021-03-3110520699core:RetainedEarningsAccumulatedLosses2020-03-3110520699bus:Director12020-04-012021-03-31105206992019-04-012020-03-3110520699core:WithinOneYear2021-03-3110520699core:WithinOneYear2020-03-3110520699bus:PrivateLimitedCompanyLtd2020-04-012021-03-3110520699bus:SmallCompaniesRegimeForAccounts2020-04-012021-03-3110520699bus:FRS1022020-04-012021-03-3110520699bus:AuditExemptWithAccountantsReport2020-04-012021-03-3110520699bus:FullAccounts2020-04-012021-03-31xbrli:purexbrli:sharesiso4217:GBP